Systemair stärker sin position inom strålningsvärme
Pressmeddelande 5 juli 2021
Systemair AB (NASDAQ OMX Stockholm: SYSR) har förvärvat resterande 50,1% av aktierna i Burda WTG i Tyskland. BURDA WTG utvecklar, producerar och levererar infraröda strålningsvärmare och värmepaneler och tillhörande reglerutrustning med flera egna patent. Huvudkontoret ligger i Eschborn, nära Frankfurt/Main, Tyskland. Omsättningen under 2020 uppgick till cirka 4 miljoner euro.
”Burda WTG är marknadsledande på infraröda värmare för utomhusapplikationer och ett perfekt komplement till Fricos produktsortiment. Burda delar också samma passion för att skapa smarta lösningar för energieffektiv uppvärmning av utomhusmiljöer som Frico AB”, säger Roland Kasper, VD, Systemair.
För ytterligare information kontakta:
Roland Kasper, CEO, + 46 73 094 40 13
Anders Ulff, CFO, + 46 70 577 40 09
Systemair AB, SE-739 30 Skinnskatteberg, Sweden, +46 222 440 00, www.systemair.com
Systemair i korthet
Systemair är ett ledande ventilationsföretag med verksamhet i 54 länder i Europa, Nordamerika, Sydamerika, Mellanöstern, Asien, Australien och Afrika. Bolaget omsatte 8,5 miljarder kronor räkenskapsåret 2020/21 och har cirka 6 400 anställda. Sedan grundandet av Systemair 1974 har bolaget uppvisat positiva rörelseresultat. Under de senaste 10 åren har den genomsnittliga tillväxten uppgått till cirka 10 procent. Systemair bidrar till att förbättra inomhusklimatet med hjälp av energieffektiva och hållbara produkter som minskar koldioxidutsläppen.
Systemair har en väletablerad verksamhet på tillväxtmarknader. Koncernens produkter marknadsförs under varumärkena Systemair, Frico, Fantech och Menerga. Systemair är sedan oktober 2007 noterat på Nasdaq OMX Nordiska börs i Stockholm på listan för medelstora bolag. Koncernen omfattar ett 90-tal bolag.
Bilaga
För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.
Om
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Följ GlobeNewswire by notified
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från GlobeNewswire by notified
Heineken Holding N.V. reports on 2024 first-quarter trading24.4.2024 08:01:00 CEST | Press release
Amsterdam, 24 April 2024 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company. Financial Summary Throughout this report figures refer to quarterly performance unless otherwise indicated. Revenue in the first quarter was €8.2 billion, up 7.2%. Net revenue (beia) was €6.8 billion, up 9.4% organically. Total consolidated volume increased 4.3% and net revenue (beia) per hectolitre
Heineken N.V. reports on 2024 first-quarter trading24.4.2024 08:00:00 CEST | Press release
Amsterdam, 24 April 2024 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. CEO Statement Dolf van den Brink, Chairman of the Executive Board / CEO, commented: "As we maintained focus on our EverGreen priorities, we had an encouraging start to 2024. All regions grew volume and net revenue, and we continued to see a sequential improvement in the performance of the business, growing in line or ahead of the category in the majority of our markets. This quarter was boosted by an earlier Easter and cycling negative one-off effects from last year. Top-line delivery w
Pharming Group to report first quarter 2024 financial results on May 824.4.2024 08:00:00 CEST | Press release
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2024. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https://register.vevent.com/register/BI6f55067b569a46d7a67be9f94edefc95 To watch the live webcast, please register in advance using the link below. Webcast registration: https://edge.media-server.com/mmc/p/ov2ruv3b About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company
EXEL Industries : Second quarter 2023–2024 sales: up 1.8%24.4.2024 07:55:00 CEST | Press release
Second quarter 2023-2024 sales: down 1.8% Varying sales performance across activities Q2 sales (January 2024–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 147.7157.4 +9.7 +6.5% +12.0 +8.1% SUGAR BEET HARVESTERS 34.317.1 -17.2 -50.1% -17.1 -49.9% LEISURE 48.447.4 -1.0 -2.0% -4.4 -9.0% INDUSTRY 67.670.7 +3.1 +4.7% +3.3 +4.9%EXEL Industries Group297.9292.6 -5.3 -1.8% -6.2 -2.1% 6-month sales (October 2023–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 236.8248.3 +11.6 +4.9% +17.0 +7.2% SUGAR BEET HARVESTERS 53.844.2 -9.6 -17.8% -8.5 -15.9% LEISURE 62.158.5 -3.6 -5.9% -8.8 -14.1% INDUSTRY 130.4141.7 +11.3 +8.7% +14.4 +11.0%EXEL Industries Group483.1492.7 +9.7 +2.0% +14.1 +2.9% * Like-for-like (LFL) = at constant consolidation scope and foreign exchange rates Second quarter 2023-2024 sales The EXEL Industries Group posted revenue of €292.6 million for the second q
Vistin Pharma ASA: First quarter 2024 financial results24.4.2024 07:44:00 CEST | Press release
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q1 2023. Sales volume in the quarter was up by 11% compared to Q1 2023. First quarter EBITDA ended at MNOK 20 compared to MNOK 14 in Q1 2023, representing a 45% increase. EBITDA positively affected by increased sales volume and product mix, partly offset by a one-time inventory adjustment of MNOK 7. The net profit ended at MNOK 7.7 for the first quarter of 2024. Net profit negatively affected with approx. MNOK 3 in the quarter by fair value of future FX cash flow hedging contracts (unrealized gain - no cash effect in quarter). Unplanned “wear and tear” maintenance/repair on Line 2 resulted in lower than planned production and sales volume in the first quarter. After the repair, line 2 has been producing according to plan from fiscal week 14. The first quarter conference call, which will be